News

Mar 09,2022

C4 Therapeutics Announces FDA Orphan Drug Designation for CFT8634 for the Treatment of Soft Tissue Sarcoma

May 19,2022

Twist Bioscience Becomes Digital Preservation Coalition Supporter

Feb 04,2022

Dewpoint Therapeutics Announces Completion of $150 Million Series C Financing

Jan 27,2022

Twist Bioscience Signs Collaboration with Artisan Bio to Engineer Next Generation Cell Therapeutics

Jan 18,2022

Dermaliq Therapeutics Signs USD 15 Million Series A Round to Advance Three Transformative Drug Therapies into the Clinics

Dec 01,2021

ITabMed Completes Series A-round Financing after Spin-off

Nov 30,2021

Expert Opinion on Investigational Drugs Publishes "An Evaluation of KBP-5074 in Advanced CKD with Uncontrolled Hypertension"

Nov 28,2021

KBP Participates in the 6th Kidney Disease Clinical Trialists Workshop

End of content

No more pages to load

Next page